Fidelity Investments’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$210M Buy
1,674,220
+365,392
+28% +$45.9M 0.01% 796
2025
Q1
$179M Buy
1,308,828
+551,258
+73% +$75.4M 0.01% 836
2024
Q4
$116M Buy
757,570
+376,356
+99% +$57.6M 0.01% 1057
2024
Q3
$73.9M Sell
381,214
-229,202
-38% -$44.4M ﹤0.01% 1212
2024
Q2
$142M Sell
610,416
-10,434
-2% -$2.42M 0.01% 911
2024
Q1
$134M Sell
620,850
-380,294
-38% -$82M 0.01% 945
2023
Q4
$259M Sell
1,001,144
-359,907
-26% -$93.1M 0.02% 648
2023
Q3
$350M Sell
1,361,051
-1,279,470
-48% -$329M 0.03% 501
2023
Q2
$752M Buy
2,640,521
+887,907
+51% +$253M 0.06% 282
2023
Q1
$487M Buy
1,752,614
+541,421
+45% +$151M 0.04% 419
2022
Q4
$335M Sell
1,211,193
-265,039
-18% -$73.4M 0.03% 523
2022
Q3
$394M Buy
1,476,232
+450,066
+44% +$120M 0.04% 435
2022
Q2
$209M Buy
1,026,166
+638,196
+164% +$130M 0.02% 662
2022
Q1
$81.7M Buy
387,970
+200,669
+107% +$42.3M 0.01% 1159
2021
Q4
$44.9M Sell
187,301
-990,252
-84% -$238M ﹤0.01% 1467
2021
Q3
$333M Sell
1,177,553
-174,665
-13% -$49.4M 0.03% 589
2021
Q2
$468M Sell
1,352,218
-562,998
-29% -$195M 0.04% 453
2021
Q1
$536M Sell
1,915,216
-66,652
-3% -$18.6M 0.05% 412
2020
Q4
$485M Buy
1,981,868
+897,042
+83% +$220M 0.04% 416
2020
Q3
$308M Sell
1,084,826
-57,568
-5% -$16.3M 0.03% 461
2020
Q2
$306M Sell
1,142,394
-1,045,442
-48% -$280M 0.03% 452
2020
Q1
$692M Buy
2,187,836
+729,227
+50% +$231M 0.1% 199
2019
Q4
$433M Sell
1,458,609
-261,063
-15% -$77.5M 0.05% 366
2019
Q3
$400M Sell
1,719,672
-322,604
-16% -$75.1M 0.05% 377
2019
Q2
$478M Sell
2,042,276
-509,390
-20% -$119M 0.06% 335
2019
Q1
$603M Sell
2,551,666
-1,119,400
-30% -$265M 0.07% 265
2018
Q4
$1.1B Sell
3,671,066
-651,121
-15% -$196M 0.15% 129
2018
Q3
$1.53B Sell
4,322,187
-1,025,928
-19% -$362M 0.17% 106
2018
Q2
$1.55B Sell
5,348,115
-1,422,922
-21% -$413M 0.18% 98
2018
Q1
$1.85B Sell
6,771,037
-2,321,382
-26% -$636M 0.22% 89
2017
Q4
$2.9B Buy
9,092,419
+1,940,450
+27% +$618M 0.34% 44
2017
Q3
$2.24B Buy
7,151,969
+1,047,943
+17% +$328M 0.27% 65
2017
Q2
$1.66B Buy
6,104,026
+561,436
+10% +$152M 0.21% 92
2017
Q1
$1.52B Sell
5,542,590
-2,657,944
-32% -$727M 0.19% 98
2016
Q4
$2.33B Sell
8,200,534
-1,518,017
-16% -$430M 0.31% 61
2016
Q3
$3.04B Sell
9,718,551
-1,723,597
-15% -$540M 0.41% 43
2016
Q2
$2.77B Sell
11,442,148
-2,050,916
-15% -$496M 0.38% 48
2016
Q1
$3.51B Buy
13,493,064
+567,069
+4% +$148M 0.49% 36
2015
Q4
$3.96B Sell
12,925,995
-3,637,805
-22% -$1.11B 0.53% 30
2015
Q3
$4.83B Sell
16,563,800
-5,174,594
-24% -$1.51B 0.69% 19
2015
Q2
$8.78B Sell
21,738,394
-302,757
-1% -$122M 1.13% 7
2015
Q1
$9.31B Buy
22,041,151
+2,253,038
+11% +$951M 1.19% 4
2014
Q4
$6.72B Buy
19,788,113
+785,319
+4% +$267M 0.87% 10
2014
Q3
$6.29B Sell
19,002,794
-2,141,978
-10% -$709M 0.85% 8
2014
Q2
$6.67B Sell
21,144,772
-780,556
-4% -$246M 0.89% 8
2014
Q1
$6.71B Sell
21,925,328
-2,116,187
-9% -$647M 0.93% 10
2013
Q4
$6.73B Sell
24,041,515
-1,598,992
-6% -$447M 0.95% 9
2013
Q3
$6.17B Buy
25,640,507
+2,111,978
+9% +$508M 0.95% 6
2013
Q2
$5.06B Buy
+23,528,529
New +$5.06B 0.83% 11